This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Nov 11;351(20):2045-8.

doi: 10.1056/NEJMp048253.

Cytokine-based therapies for Crohn's disease--new paradigms

Fabio Cominelli¹

Affiliations

PMID: 15537904
DOI: 10.1056/NEJMp048253

Comment

Cytokine-based therapies for Crohn's disease--new paradigms

Fabio Cominelli. N Engl J Med. 2004.

. 2004 Nov 11;351(20):2045-8.

doi: 10.1056/NEJMp048253.

Author

Fabio Cominelli¹

Affiliation

¹ Health Sciences Center, University of Virginia, Charlottesville, USA.

PMID: 15537904
DOI: 10.1056/NEJMp048253

No abstract available

PubMed Disclaimer

Comment on

Anti-interleukin-12 antibody for active Crohn's disease.
Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, Dolin B, Goodman N, Groden C, Hornung RL, Quezado M, Yang Z, Neurath MF, Salfeld J, Veldman GM, Schwertschlag U, Strober W; Anti-IL-12 Crohn's Disease Study Group. Mannon PJ, et al. N Engl J Med. 2004 Nov 11;351(20):2069-79. doi: 10.1056/NEJMoa033402. N Engl J Med. 2004. PMID: 15537905 Clinical Trial.

Similar articles

Anti-interleukin-12 antibody for active Crohn's disease.
Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, Dolin B, Goodman N, Groden C, Hornung RL, Quezado M, Yang Z, Neurath MF, Salfeld J, Veldman GM, Schwertschlag U, Strober W; Anti-IL-12 Crohn's Disease Study Group. Mannon PJ, et al. N Engl J Med. 2004 Nov 11;351(20):2069-79. doi: 10.1056/NEJMoa033402. N Engl J Med. 2004. PMID: 15537905 Clinical Trial.
Anti-interleukin-12 antibody for active Crohn's disease.
Orenstein R. Orenstein R. N Engl J Med. 2005 Feb 10;352(6):627-8; author reply 627-8. doi: 10.1056/NEJM200502103520619. N Engl J Med. 2005. PMID: 15703432 No abstract available.
How deep is remission in perianal Crohn's disease and do imaging modalities matter?
Savoye G, Savoye-Collet C. Savoye G, et al. Am J Gastroenterol. 2010 Jun;105(6):1445-6; author reply 1446. doi: 10.1038/ajg.2010.35. Am J Gastroenterol. 2010. PMID: 20523317 No abstract available.
Biologic therapy in Crohn's disease.
Williams MD, Omran ML, Gordon GL. Williams MD, et al. Mo Med. 2009 Sep-Oct;106(5):356-60. Mo Med. 2009. PMID: 19902717 Review.
Therapeutic inhibitors of tumor necrosis factor in Crohn's disease.
Ganesan S, Travis SP, Ahmad T, Jazrawi R. Ganesan S, et al. Curr Opin Investig Drugs. 2002 Sep;3(9):1301-6. Curr Opin Investig Drugs. 2002. PMID: 12498004 Review.

See all similar articles

Cited by

Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism.
Corridoni D, Pastorelli L, Mattioli B, Locovei S, Ishikawa D, Arseneau KO, Chieppa M, Cominelli F, Pizarro TT. Corridoni D, et al. PLoS One. 2012;7(7):e42067. doi: 10.1371/journal.pone.0042067. Epub 2012 Jul 25. PLoS One. 2012. PMID: 22848704 Free PMC article.
Infliximab: Use in Inflammatory Bowel Disease.
Travassos WJ, Cheifetz AS. Travassos WJ, et al. Curr Treat Options Gastroenterol. 2005 Jun;8(3):187-196. doi: 10.1007/s11938-005-0011-2. Curr Treat Options Gastroenterol. 2005. PMID: 15913508
Effects of structured exercise programmes on physiological and psychological outcomes in adults with inflammatory bowel disease (IBD): A systematic review and meta-analysis.
Jones K, Kimble R, Baker K, Tew GA. Jones K, et al. PLoS One. 2022 Dec 1;17(12):e0278480. doi: 10.1371/journal.pone.0278480. eCollection 2022. PLoS One. 2022. PMID: 36454911 Free PMC article.
The Potential Association Between Inflammatory Bowel Diseases and Apical Periodontitis: A Systematic Review and Meta-Analysis.
Halboub E, Al-Maswary A, Mashyakhy M, Al-Qadhi G, Al-Maweri SA, Ba-Hattab R, Abdulrab S. Halboub E, et al. Eur Endod J. 2024 Jan 1;9(1):8-17. doi: 10.14744/eej.2023.74507. Epub 2023 Nov 16. Eur Endod J. 2024. PMID: 37968968 Free PMC article.
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.
Pastorelli L, Garg RR, Hoang SB, Spina L, Mattioli B, Scarpa M, Fiocchi C, Vecchi M, Pizarro TT. Pastorelli L, et al. Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):8017-22. doi: 10.1073/pnas.0912678107. Epub 2010 Apr 12. Proc Natl Acad Sci U S A. 2010. PMID: 20385815 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information